Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-000160

Chief Executive Officer gave up 7,141 shares (to pay taxes)

  • Chief Executive Officer acquired 20,635 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2022-12-31 Option exercise +13,912 77,147.8 D: show line 1 in the form
Robinson Chandler Chief Executive Officer 2022-12-31 Shares withheld for taxes −4,814 $2.37 $11,409 72,333.8 D: show line 2 in the form
Robinson Chandler Chief Executive Officer 2023-01-01 Option exercise +6,723 79,056.8 D: show line 3 in the form
Robinson Chandler Chief Executive Officer 2023-01-01 Shares withheld for taxes −2,327 $2.37 $5,515 76,729.8 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Robinson Chandler Chief Executive Officer 2022-12-31 Option exercise · Restricted Stock Units −13,912 151,171 D: show line 5 in the form
Robinson Chandler Chief Executive Officer 2023-01-01 Option exercise · Restricted Stock Units −6,723 6,724 D: show line 6 in the form
Loading xslF345X03/rdgdoc.xml…